0001104659-16-151423.txt : 20161024
0001104659-16-151423.hdr.sgml : 20161024
20161024060127
ACCESSION NUMBER: 0001104659-16-151423
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160930
FILED AS OF DATE: 20161024
DATE AS OF CHANGE: 20161024
EFFECTIVENESS DATE: 20161024
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 161947165
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
09-30-2016
09-30-2016
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
(415) 801-8100
/s/ Robin L. Praeger
San Francisco
CA
10-20-2016
0
7
89691641
false
INFORMATION TABLE
2
a16-20248_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
14687347
407416
SH
OTR
0
407416
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
2034286
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
6136718
1281152
SH
OTR
0
1281152
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
15219688
2215384
SH
OTR
0
2215384
0
Glaukos Corporation
Common Stock
377322102
2695693
71428
SH
OTR
0
71428
0
Audentes Therapeutics, Inc.
Common Stock
05070R104
32179678
1806832
SH
OTR
0
1806832
0
Immune Design Corp.
Common Stock
45252L103
16738232
2208210
SH
OTR
0
2208210
0